Intrinsic Value

GenSight Biologics S.A. (SIGHT.PA)

0.414 €

+0.01 (+1.72%)

Enterprise Value -4,205.22
Net Debt 16.29
Equity Value -4,221.51
Shares Outstanding 48.32
Equity Value Per Share -87.37



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt